INOTUZUMAB OZOGAMICIN for Acute lymphocytic leukaemia recurrent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 170 adverse event reports in the FDA FAERS database where INOTUZUMAB OZOGAMICIN was used for Acute lymphocytic leukaemia recurrent.
Most Reported Side Effects for INOTUZUMAB OZOGAMICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 253 | 10.9% | 253 | 14 |
| Febrile neutropenia | 230 | 9.9% | 36 | 174 |
| Venoocclusive liver disease | 229 | 9.9% | 114 | 72 |
| Neoplasm progression | 158 | 6.8% | 104 | 26 |
| Pyrexia | 151 | 6.5% | 34 | 109 |
| Off label use | 146 | 6.3% | 63 | 38 |
| Sepsis | 119 | 5.1% | 75 | 55 |
| Venoocclusive disease | 109 | 4.7% | 44 | 37 |
| Thrombocytopenia | 108 | 4.7% | 23 | 47 |
| Platelet count decreased | 107 | 4.6% | 31 | 66 |
| Drug ineffective | 92 | 4.0% | 39 | 27 |
| Neutropenia | 90 | 3.9% | 33 | 33 |
| Cytokine release syndrome | 84 | 3.6% | 24 | 38 |
| Pneumonia | 83 | 3.6% | 39 | 52 |
| Blood bilirubin increased | 77 | 3.3% | 23 | 36 |
Other Indications for INOTUZUMAB OZOGAMICIN
Acute lymphocytic leukaemia (948)
B-cell type acute leukaemia (210)
B precursor type acute leukaemia (104)
Product used for unknown indication (100)
Diffuse large b-cell lymphoma (88)
Non-hodgkin's lymphoma (56)
Acute lymphocytic leukaemia refractory (31)
Precursor b-lymphoblastic lymphoma (19)
Acute leukaemia (15)
Leukaemia (14)
Other Drugs Used for Acute lymphocytic leukaemia recurrent
BLINATUMOMAB (783)
VINCRISTINE (339)
METHOTREXATE (318)
DEXAMETHASONE (266)
CYCLOPHOSPHAMIDE (243)
CYTARABINE (233)
TISAGENLECLEUCEL (225)
PONATINIB (195)
PEGASPARGASE (172)
DOXORUBICIN (146)